© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Javier Morales, MD, FACP, FACE
Articles
Referral and Screening for Progression
December 04, 2024
Panelists discuss how delaying intervention between stage II and stage III T1D can result in irreversible β-cell loss, higher rates of complications, and poorer overall outcomes for patients.
Stages of T1D Progression
December 04, 2024
Panelists discuss how understanding the stages of type 1 diabetes (T1D) progression is crucial for early intervention, with a focus on delaying disease advancement through proactive treatments like teplizumab.
Consequences of Delaying Intervention
December 04, 2024
Panelists discuss how delaying intervention in stage 2 T1D can lead to faster disease progression, increased risk of complications like diabetic ketoacidosis, and greater long-term burden on patient health and quality of life.
Examining the Burden of T1D
December 04, 2024
Panelists highlight the burden of type 1 diabetes including the significant physical, emotional, and financial challenges faced by patients and their families, emphasizing the need for early intervention and proactive management strategies.
Patient Case 2: Tailoring Treatment for Complex Needs, Incorporating Cardiovascular, Weight, and Renal Considerations
July 16, 2024
The expert panel concludes by analyzing a patient case and offering final insights on customizing treatment for complex geriatric diabetes patients, taking into account cardiovascular health, weight management, and renal function considerations.
Optimizing Treatment: Expert Insights on Streamlining and Deprescribing for Older Adults with T2D
July 16, 2024
Key opinion leaders explore methods for optimizing treatment in older adults with type 2 diabetes, focusing on streamlining regimens and the process of deprescribing, with particular emphasis on defining and implementing the deprescribing approach.
Managing Treatment Changes in Older Adults with T2D: Approaches, Burdens, and Benefits of Combination Therapy
July 16, 2024
Experts examine strategies for managing treatment modifications in older adults with type 2 diabetes, weighing the approaches, challenges, and advantages of combination therapy regimens.
Insulin Therapy: Dosing Considerations, Injectable Options, and Tailoring for Glucose Control
July 16, 2024
Leading experts in geriatric diabetes care explore comprehensive aspects of insulin therapy, including dosing strategies, available injectable options, and methods for tailoring glucose control in elderly patients.
Patient Case Review: Investigating Treatment Profiles, Exploring the Role of Treatment Adherence and Drug Class Selection Considerations
July 16, 2024
The panelists analyze a patient case, examining treatment profiles, adherence factors, and drug class selection criteria while discussing strategies to enhance elderly care.
Optimizing Geriatric Care: ADA Guidelines for Glycemic Goals and Long-Term Care Management
July 16, 2024
Key opinion leaders explore strategies for enhancing elderly patient care by implementing American Diabetes Association guidelines on glycemic targets and long-term management in geriatric settings.